Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Not applicableLooking for participantsNCT06927219
What this trial is testing

Research Accelerated by You Lupus Registry

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)
Lupus Foundation of America 10,000
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Early research (Phase 1)Study completedNCT03817424
What this trial is testing

Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more
Amgen 31
Testing effectiveness (Phase 2)Study completedNCT03288324
What this trial is testing

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Who this might be right for
Cutaneous LupusSystemic Lupus Erythematosus
Children's Hospital Medical Center, Cincinnati 13
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327
What this trial is testing

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Who this might be right for
Systemic Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Testing effectiveness (Phase 2)Looking for participantsNCT07694336
What this trial is testing

Quinacrine in Participants With Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Victoria Werth 24
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Early research (Phase 1)Ended earlyNCT02428309
What this trial is testing

Autologous Polyclonal Tregs for Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic
National Institute of Allergy and Infectious Diseases (NIAID) 1
Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48
Post-approval studies (Phase 4)Study completedNCT03122431
What this trial is testing

Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Juvenile SLECutaneous Lupus
University of Sao Paulo General Hospital 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Early research (Phase 1)Looking for participantsNCT06708845
What this trial is testing

US Zamto-cel Autoimmune Diseases

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more
Miltenyi Biomedicine GmbH 48
Post-approval studies (Phase 4)Looking for participantsNCT06875960
What this trial is testing

Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Who this might be right for
Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb 35
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Testing effectiveness (Phase 2)Study completedNCT02847598
What this trial is testing

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus
Biogen 264
Large-scale testing (Phase 3)Active Not RecruitingNCT04877691
What this trial is testing

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 367
Next Page